New strategies for allogeneic bone marrow transplantation and organ allografts

Acta Haematologica

Volumn 101, Issue 2, 1999, Pages 68-77

  Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Allogeneic bone marrow transplantation; Autoimmune diseases; Organ allograft; Portal venous injection

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AUTOIMMUNE DISEASE; BONE GRAFT; BONE MARROW CELL; CHIMERA; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; IRRADIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PANCREAS TRANSPLANTATION; PORTAL VEIN; PRIORITY JOURNAL; RAT; SKIN ALLOGRAFT; SWINE; T LYMPHOCYTE; THYMUS FUNCTION;

EID: 0032926571     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040927     Document Type: Conference Paper

References (32)

1. Ikehara S, Good RA, Nakamura T, Sekita K, Inoue S, Oo MM, Muso E, Ogawa K, Hamashima Y: Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985;82:2483-2487.
2. Ikehara S, Ohtsuki H, Good RA, Asamoto H, Nakamura T, Sekita K, Muso E, Tochino Y, Ida T, Kuzuya, H, Imura H, Hamashima Y: Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1985;82: 7743-7747.
3. Yasumizu R, Sugiura K, Iwai H, Inaba M, Makino S, Ida T, Imura H, Hamashima Y, Good RA, Ikehara S: Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc Natl Acad Sci USA 1987;84:6555-6557.
4. Oyaizu N, Yasumizu R, Inaba-Miyama M, Nomura S, Yoshida H, Miyawaki S, Shibata Y, Mitsuoka S, Yasunaga K, Morii S, Good RA, Ikehara S: (NZW × BXSB)F1 mouse. A new model of idiopathic thrombocytopenic purpura. J Exp Med 1988;167:2017-2022.
5. Ikehara S, Yasumizu R, Inaba M, Izui S, Hayakawa K, Sekita K, Toki J, Sugiura K, Iwai H, Nakamura T, Muso E, Hamashima Y, Good RA: Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1989;86:3306-3310.
6. Adachi Y, Inaba M, Amoh Y, Yoshifusa H, Nakamura Y, Suzuki H, Akamatu S, Nakai S, Haruna H, Adachi M, Ikehara S: Effects of bone marrow transplantation on antiphospho-lipid antibody syndrome in murine lupus mice. Immunobiology 1995;192:218-230.
7. Than S, Ishida H, Inaba M, Fukuba Y, Seino Y, Adachi M, Imura H, Ikehara S: Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J Exp Med 1992;176:1233-1238.
8. Nishimura M, Toki J, Sugiura K, Hashimoto F, Tomita T, Fujishima H, Hiramatsu Y, Nishioka N, Nagata N, Takahashi Y, Ikehara S: Focal glomerulonephritis is a stem cell disorder. J Exp Med 1994;179:1053-1058.
9. Ikehara S, Kawamura M, Takao F, Inaba M, Yasumizu R, Than S, Hisha H, Sugiura K, Koide Y, Yoshida TO, Ida T, Imura H, Good RA: Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990;87: 8341-8344.
10. Kawamura M, Hisha H, Li Y, Fukuhara S, Ikehara S: Distinct qualitative differences between normal and abnormal hemopoietic stem cells in vivo and in vitro. Stem Cells 1997;15:56-62.
11. Ishida T, Inaba M, Hisha H, Sugiura K, Adachi Y, Nagata N, Ogawa R, Good RA, Ikehara S: Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation: Complete prevention of recurrence of autoimmune diseases in MRL/ MP-lpr/lpr mice by transplantation of bone marrow plus bone (stromal cells) from the same donor. J Immunol 1994;152:3119-3127.
12. Takeuchi K, Inaba M, Miyashima S, Ogawa R, Ikehara S: A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice. Blood 1998;91:4616-4623.
13. Nakamura T, Good RA, Inoue S, Oo MM, Hamashima Y, Ikehara S: Successful liver allografts in mice by combination with allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1986;83:4529-4532.
14. Zhang Y, Yasumizu R, Sugiura K, Hashimoto F, Amoh Y, Lian Z, Cherry, Nishio N, Ikehara S: Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation for the mechanism of tolerance induction by portal vein injection. Eur J Immunol 1994;24:1558-1565.
15. Hashimoto F, Sugiura K, Inoue K, Ikehara S: Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 1997;89:49-54.
16. Cherry, Yasumizu R, Toki J, Asou H, Nishino T, Komatsu Y, Ikehara S: Production of hemopoietic stem cell-chemotactic factor by bone marrow stromal cells. Blood 1994;83:964-971.
17. Drizlikh G, Schmidt-Sole J, Yankelevich B: Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts. J Exp Med 1984;159:1070-1082.
18. Onoe K, Fernandes G, Good RA: Humoral and cell-mediated immune response in fully allogeneic bone marrow chimera in mice. J Exp Med 1980;151:115-132.
19. Rayfiel LS, Brent L: Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras. Transplantation 1983;36:183-189.
20. Krown SE, Coico R, Scheid MP, Fernandes G, Good RA: Immune function in fully allogeneic mouse bone marrow chimeras. Clin Immunol Immunopathol 1981;19:268-283.
21. Li Y, Hisha H, Inaba M, Lian Z, Yu C, Kawamura M, Yamamoto Y, Nishio N, Nishimura T, Habu S, Kasai M, Hirokawa K, Fan H, Ikehara S: Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts; a role of the stromal cells in positive selection. Submitted.
22. Marmont AM: Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases? Stem Cells 1994;12:125-135.
23. Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M, Zander AR, Schalke B, Hahn Y, Haas R, Schmitz N: Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996;88:3621-3625.
24. Nelson JL, Torrez R, Louie FM, Choe OS, Strob R, Sullivan KM: Pre-existing autoimmune diseases in patients with long-term survival after allogeneic bone marrow transplantation. J Rheumatol 1997;24:23-29.
25. Karussis DM, Vourka-Karussis U, Lehmann D, Abramsky O, Ben-Nun A, Slavin S: Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation. Clin Exp Immunol 1995;100:111.
26. Hosaka N, Nose M, Kyogoku M, Nagata N, Miyashima S, Good RA, Ikehara S: Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+ mice. Proc Natl Acad Sci USA 1996;93:8558-8562.
27. Sugiura K, Kato K, Hashimoto F, Jin T, Amoh Y, Yamamoto Y, Morita H, Okumura K, Ikehara S: Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells. Immunobiology 1997;197:460-477.
28. Vriens PW, Nisco S, Hoyt EG, Lyu S, Pierre P, Reitz BA, Clayberger C: Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats. Transplantation 1994;57:1795-1798.
29. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M: Cell migration, chimerism, and graft acceptance. Lancet 1992;339: 1579-1582.
30. Starzl TE, Demetris AJ, Trucco M, Ricordi C, Ildstad C, Terasaki PI, Murase N, Kendall RS, Kocova M, Rudert WA: Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med 1993;328:745-749.
31. Morita H, Sugiura K, Inaba M, Jin T, Ishikawa J, Lian Z, Adachi Y, Sogo S, Yamanishi K, Taki H, Adachi M, Noumi T, Kamiyama Y, Good RA, Ikehara S: A strategy for organ allografts without using immunosuppressants or irradiation. Proc Natl Acad Sci USA 1998;95: 6947-6952.
32. Morita H, Nakamura N, Sugiura K, Satoi S, Wei T, Sakakura Y, Yoshida K, Oda M, Inoue T, Inui H, Nagahama T, Kamiyama Y, Ikehara S: Acceptance of skin allografts in pigs by portal venous injection of donor bone marrow cells. Submitted.